Clinical Trial Update: Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing neuroinflammation in central inflammatory disorders using the PET radioligand [F-18]DPA-714; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue Syndrome
• Fibromyalgia

Drugs mentioned

• [F-18]DPA-714 (DPA-714)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Fibromyalgia, Chronic Fatigue Syndrome | Phase 1 | Status: RECRUITING